{"entity":{"type":"insider","cik":"0001376043","url":"/insider/0001376043","json_url":"/insider/0001376043.json","name":"Coughlin Timothy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":52,"n_filings":36,"first":"2008-02-14","last":"2026-06-16","span_basis":"filed_date"},"name_variants":[{"name":"Coughlin Timothy","source":"filing","n_filings":3,"first_seen":"2025-11-04","last_seen":"2026-06-16"},{"name":"COUGHLIN TIMOTHY","source":"filing","n_filings":2,"first_seen":"2022-06-06","last_seen":"2024-06-03"},{"name":"Coughlin Timothy P","source":"filing","n_filings":31,"first_seen":"2008-02-14","last_seen":"2017-02-08"}],"transactions":[{"id":5874850,"accession":"0001376043-26-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001376043-26-000010","line_url":"/filing/0001376043-26-000010#line-2","is_derivative":false,"issuer_cik":"0001376043","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001376043","owner_cik":"0001376043","owner_name":"Coughlin Timothy","owner_display_name":"Coughlin Timothy","owner_url":"/insider/0001376043","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.0747,"price_display":"50.07","price_state":"stated","total_value":500747.0,"total_display":"500,747.00","total_whole":"500,747","shares_owned_after":56250.0,"shares_owned_after_display":"56,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-16","scope":"insider"},{"id":6091450,"accession":"0001376043-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001376043-26-000005","line_url":"/filing/0001376043-26-000005#line-1","is_derivative":false,"issuer_cik":"0001376043","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001376043","owner_cik":"0001376043","owner_name":"Coughlin Timothy","owner_display_name":"Coughlin Timothy","owner_url":"/insider/0001376043","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3250.0,"shares_display":"3,250","price_per_share":43.49,"price_display":"43.49","price_state":"stated","total_value":141342.5,"total_display":"141,342.50","total_whole":"141,343","shares_owned_after":52250.0,"shares_owned_after_display":"52,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-19","scope":"insider"},{"id":4950899,"accession":"0001376043-25-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001376043-25-000004","line_url":"/filing/0001376043-25-000004#line-3","is_derivative":false,"issuer_cik":"0001376043","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001376043","owner_cik":"0001376043","owner_name":"Coughlin Timothy","owner_display_name":"Coughlin Timothy","owner_url":"/insider/0001376043","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":35.0334,"price_display":"35.03","price_state":"stated","total_value":630601.2,"total_display":"630,601.20","total_whole":"630,601","shares_owned_after":55500.0,"shares_owned_after_display":"55,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-31","filed_date":"2025-11-04","scope":"insider"},{"id":2082037,"accession":"0000950170-24-067989","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-067989","line_url":"/filing/0000950170-24-067989#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001376043","owner_name":"COUGHLIN TIMOTHY","owner_display_name":"COUGHLIN TIMOTHY","owner_url":"/insider/0001376043","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":87500.0,"total_display":"87,500.00","total_whole":"87,500","shares_owned_after":56000.0,"shares_owned_after_display":"56,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-06-03","scope":"insider"},{"id":6892285,"accession":"0001209191-22-034541","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-034541","line_url":"/filing/0001209191-22-034541#line-1","is_derivative":false,"issuer_cik":"0001376043","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001376043","owner_cik":"0001376043","owner_name":"COUGHLIN TIMOTHY","owner_display_name":"COUGHLIN TIMOTHY","owner_url":"/insider/0001376043","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1439.0,"shares_display":"1,439","price_per_share":22.81,"price_display":"22.81","price_state":"stated","total_value":32823.59,"total_display":"32,823.59","total_whole":"32,824","shares_owned_after":57632.0,"shares_owned_after_display":"57,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-06","scope":"insider"},{"id":4732897,"accession":"0001209191-17-008909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-008909","line_url":"/filing/0001209191-17-008909#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":963.0,"shares_display":"963","price_per_share":43.14,"price_display":"43.14","price_state":"stated","total_value":41543.82,"total_display":"41,543.82","total_whole":"41,544","shares_owned_after":137961.0,"shares_owned_after_display":"137,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-08","scope":"insider"},{"id":4194508,"accession":"0001209191-17-008136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-008136","line_url":"/filing/0001209191-17-008136#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":42.55,"price_display":"42.55","price_state":"stated","total_value":63825.0,"total_display":"63,825.00","total_whole":"63,825","shares_owned_after":136324.0,"shares_owned_after_display":"136,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-03","filed_date":"2017-02-06","scope":"insider"},{"id":5059436,"accession":"0001209191-17-004305","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-004305","line_url":"/filing/0001209191-17-004305#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":40.65,"price_display":"40.65","price_state":"stated","total_value":71137.5,"total_display":"71,137.50","total_whole":"71,138","shares_owned_after":134824.0,"shares_owned_after_display":"134,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-18","scope":"insider"},{"id":4214914,"accession":"0001209191-17-003584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-003584","line_url":"/filing/0001209191-17-003584#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":43.37,"price_display":"43.37","price_state":"stated","total_value":75897.5,"total_display":"75,897.50","total_whole":"75,898","shares_owned_after":133124.0,"shares_owned_after_display":"133,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-10","filed_date":"2017-01-12","scope":"insider"},{"id":2256973,"accession":"0001209191-16-152153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-152153","line_url":"/filing/0001209191-16-152153#line-1","is_derivative":false,"issuer_cik":"0001376043","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001376043","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56390.0,"shares_display":"56,390","price_per_share":2.66,"price_display":"2.66","price_state":"stated","total_value":149997.4,"total_display":"149,997.40","total_whole":"149,997","shares_owned_after":56390.0,"shares_owned_after_display":"56,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-23","filed_date":"2016-11-28","scope":"insider"},{"id":2695705,"accession":"0001209191-16-095848","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-095848","line_url":"/filing/0001209191-16-095848#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":38.06,"price_display":"38.06","price_state":"stated","total_value":57090.0,"total_display":"57,090.00","total_whole":"57,090","shares_owned_after":131374.0,"shares_owned_after_display":"131,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-03","filed_date":"2016-02-04","scope":"insider"},{"id":2873839,"accession":"0001209191-16-092884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-092884","line_url":"/filing/0001209191-16-092884#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":46.69,"price_display":"46.69","price_state":"stated","total_value":81707.5,"total_display":"81,707.50","total_whole":"81,708","shares_owned_after":129874.0,"shares_owned_after_display":"129,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-19","filed_date":"2016-01-21","scope":"insider"},{"id":2093538,"accession":"0001209191-16-091250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-091250","line_url":"/filing/0001209191-16-091250#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":44.25,"price_display":"44.25","price_state":"stated","total_value":77437.5,"total_display":"77,437.50","total_whole":"77,438","shares_owned_after":128124.0,"shares_owned_after_display":"128,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-13","scope":"insider"},{"id":8944156,"accession":"0001209191-15-076197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-076197","line_url":"/filing/0001209191-15-076197#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":47.78,"price_display":"47.78","price_state":"stated","total_value":1194500.0,"total_display":"1,194,500.00","total_whole":"1,194,500","shares_owned_after":126374.0,"shares_owned_after_display":"126,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-16","filed_date":"2015-10-19","scope":"insider"},{"id":8094126,"accession":"0001209191-15-061949","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-061949","line_url":"/filing/0001209191-15-061949#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":1100000.0,"total_display":"1,100,000.00","total_whole":"1,100,000","shares_owned_after":101374.0,"shares_owned_after_display":"101,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-20","filed_date":"2015-07-21","scope":"insider"},{"id":8253881,"accession":"0001209191-15-060833","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-060833","line_url":"/filing/0001209191-15-060833#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","total_whole":"1,000,000","shares_owned_after":101374.0,"shares_owned_after_display":"101,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-13","filed_date":"2015-07-14","scope":"insider"},{"id":8461301,"accession":"0001209191-15-051964","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-051964","line_url":"/filing/0001209191-15-051964#line-3","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":45.08,"price_display":"45.08","price_state":"stated","total_value":2704800.0,"total_display":"2,704,800.00","total_whole":"2,704,800","shares_owned_after":101374.0,"shares_owned_after_display":"101,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-10","scope":"insider"},{"id":8215971,"accession":"0001209191-15-028992","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-028992","line_url":"/filing/0001209191-15-028992#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":44.49,"price_display":"44.49","price_state":"stated","total_value":1779600.0,"total_display":"1,779,600.00","total_whole":"1,779,600","shares_owned_after":101374.0,"shares_owned_after_display":"101,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-24","scope":"insider"},{"id":8807436,"accession":"0000914475-15-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-15-000049","line_url":"/filing/0000914475-15-000049#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":30.81,"price_display":"30.81","price_state":"stated","total_value":53917.5,"total_display":"53,917.50","total_whole":"53,918","shares_owned_after":101374.0,"shares_owned_after_display":"101,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-21","scope":"insider"},{"id":8317004,"accession":"0000914475-15-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-15-000033","line_url":"/filing/0000914475-15-000033#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":28.37,"price_display":"28.37","price_state":"stated","total_value":49647.5,"total_display":"49,647.50","total_whole":"49,648","shares_owned_after":99624.0,"shares_owned_after_display":"99,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-13","scope":"insider"},{"id":8653818,"accession":"0000914475-15-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-15-000016","line_url":"/filing/0000914475-15-000016#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":27.25,"price_display":"27.25","price_state":"stated","total_value":272500.0,"total_display":"272,500.00","total_whole":"272,500","shares_owned_after":97874.0,"shares_owned_after_display":"97,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-09","scope":"insider"},{"id":7036134,"accession":"0001209191-14-077169","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-077169","line_url":"/filing/0001209191-14-077169#line-5","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":24.02,"price_display":"24.02","price_state":"stated","total_value":240200.0,"total_display":"240,200.00","total_whole":"240,200","shares_owned_after":97874.0,"shares_owned_after_display":"97,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-19","filed_date":"2014-12-19","scope":"insider"},{"id":7036129,"accession":"0001209191-14-077169","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-077169","line_url":"/filing/0001209191-14-077169","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":23.18,"price_display":"23.18","price_state":"stated","total_value":463600.0,"total_display":"463,600.00","total_whole":"463,600","shares_owned_after":107874.0,"shares_owned_after_display":"107,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-18","filed_date":"2014-12-19","scope":"insider","n_lines":2},{"id":6330254,"accession":"0000914475-14-000081","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-14-000081","line_url":"/filing/0000914475-14-000081","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":21.475,"price_display":"21.48","price_state":"stated","total_value":429500.0,"total_display":"429,500.00","total_whole":"429,500","shares_owned_after":97874.0,"shares_owned_after_display":"97,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-12","scope":"insider","n_lines":2},{"id":6593976,"accession":"0001209191-14-072294","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-072294","line_url":"/filing/0001209191-14-072294#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.14,"price_display":"20.14","price_state":"stated","total_value":201400.0,"total_display":"201,400.00","total_whole":"201,400","shares_owned_after":97874.0,"shares_owned_after_display":"97,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-28","filed_date":"2014-12-02","scope":"insider"},{"id":6173537,"accession":"0000914475-14-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-14-000066","line_url":"/filing/0000914475-14-000066#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":190000.0,"total_display":"190,000.00","total_whole":"190,000","shares_owned_after":97874.0,"shares_owned_after_display":"97,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-31","filed_date":"2014-11-03","scope":"insider"},{"id":6248078,"accession":"0000914475-14-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-14-000064","line_url":"/filing/0000914475-14-000064#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.62,"price_display":"18.62","price_state":"stated","total_value":186200.0,"total_display":"186,200.00","total_whole":"186,200","shares_owned_after":97874.0,"shares_owned_after_display":"97,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-30","filed_date":"2014-10-30","scope":"insider"},{"id":6248074,"accession":"0000914475-14-000064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-14-000064","line_url":"/filing/0000914475-14-000064#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","total_whole":"180,000","shares_owned_after":97874.0,"shares_owned_after_display":"97,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-28","filed_date":"2014-10-30","scope":"insider"},{"id":6512644,"accession":"0000914475-14-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-14-000021","line_url":"/filing/0000914475-14-000021#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":18.56,"price_display":"18.56","price_state":"stated","total_value":32480.0,"total_display":"32,480.00","total_whole":"32,480","shares_owned_after":97874.0,"shares_owned_after_display":"97,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-10","filed_date":"2014-01-13","scope":"insider"},{"id":6984429,"accession":"0000914475-14-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-14-000009","line_url":"/filing/0000914475-14-000009#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":16.75,"price_display":"16.75","price_state":"stated","total_value":1172500.0,"total_display":"1,172,500.00","total_whole":"1,172,500","shares_owned_after":96124.0,"shares_owned_after_display":"96,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-07","filed_date":"2014-01-08","scope":"insider"},{"id":5002874,"accession":"0000914475-13-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-13-000071","line_url":"/filing/0000914475-13-000071#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19035.0,"shares_display":"19,035","price_per_share":15.05,"price_display":"15.05","price_state":"stated","total_value":286476.75,"total_display":"286,476.75","total_whole":"286,477","shares_owned_after":96124.0,"shares_owned_after_display":"96,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-21","filed_date":"2013-08-22","scope":"insider"},{"id":5553167,"accession":"0000914475-13-000064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-13-000064","line_url":"/filing/0000914475-13-000064#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10965.0,"shares_display":"10,965","price_per_share":14.99,"price_display":"14.99","price_state":"stated","total_value":164365.35,"total_display":"164,365.35","total_whole":"164,365","shares_owned_after":96124.0,"shares_owned_after_display":"96,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-05","filed_date":"2013-08-07","scope":"insider"},{"id":9001190,"accession":"0000914475-11-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-11-000011","line_url":"/filing/0000914475-11-000011#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12320.0,"shares_display":"12,320","price_per_share":6.8266,"price_display":"6.83","price_state":"stated","total_value":84103.712,"total_display":"84,103.71","total_whole":"84,104","shares_owned_after":96124.0,"shares_owned_after_display":"96,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-28","filed_date":"2011-03-02","scope":"insider"},{"id":7657660,"accession":"0000914475-10-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-10-000027","line_url":"/filing/0000914475-10-000027#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12650.0,"shares_display":"12,650","price_per_share":2.5274,"price_display":"2.53","price_state":"stated","total_value":31971.61,"total_display":"31,971.61","total_whole":"31,972","shares_owned_after":75110.0,"shares_owned_after_display":"75,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-01","filed_date":"2010-03-03","scope":"insider"},{"id":7657658,"accession":"0000914475-10-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-10-000010","line_url":"/filing/0000914475-10-000010#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8697.0,"shares_display":"8,697","price_per_share":2.524,"price_display":"2.52","price_state":"stated","total_value":21951.228,"total_display":"21,951.23","total_whole":"21,951","shares_owned_after":54427.0,"shares_owned_after_display":"54,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-12","filed_date":"2010-01-13","scope":"insider"},{"id":5706089,"accession":"0000914475-09-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-09-000027","line_url":"/filing/0000914475-09-000027#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12117.0,"shares_display":"12,117","price_per_share":3.428,"price_display":"3.43","price_state":"stated","total_value":41537.076,"total_display":"41,537.08","total_whole":"41,537","shares_owned_after":43790.0,"shares_owned_after_display":"43,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-30","filed_date":"2009-04-01","scope":"insider"},{"id":5747111,"accession":"0000914475-09-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-09-000016","line_url":"/filing/0000914475-09-000016#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8463.0,"shares_display":"8,463","price_per_share":3.3851,"price_display":"3.39","price_state":"stated","total_value":28648.1013,"total_display":"28,648.10","total_whole":"28,648","shares_owned_after":22574.0,"shares_owned_after_display":"22,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-13","filed_date":"2009-01-15","scope":"insider"},{"id":3843317,"accession":"0000914475-08-000016","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000914475-08-000016","line_url":"/filing/0000914475-08-000016#line-13","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":7000.0,"total_display":"7,000.00","total_whole":"7,000","shares_owned_after":16004.0,"shares_owned_after_display":"16,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"},{"id":3843315,"accession":"0000914475-08-000016","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000914475-08-000016","line_url":"/filing/0000914475-08-000016#line-12","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":5.04,"price_display":"5.04","price_state":"stated","total_value":5544.0,"total_display":"5,544.00","total_whole":"5,544","shares_owned_after":13604.0,"shares_owned_after_display":"13,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"},{"id":3843313,"accession":"0000914475-08-000016","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000914475-08-000016","line_url":"/filing/0000914475-08-000016#line-11","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":5.05,"price_display":"5.05","price_state":"stated","total_value":5050.0,"total_display":"5,050.00","total_whole":"5,050","shares_owned_after":12604.0,"shares_owned_after_display":"12,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"},{"id":3843311,"accession":"0000914475-08-000016","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000914475-08-000016","line_url":"/filing/0000914475-08-000016#line-10","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":4.98,"price_display":"4.98","price_state":"stated","total_value":4980.0,"total_display":"4,980.00","total_whole":"4,980","shares_owned_after":17804.0,"shares_owned_after_display":"17,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"},{"id":3843310,"accession":"0000914475-08-000016","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000914475-08-000016","line_url":"/filing/0000914475-08-000016#line-9","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":3514.0,"total_display":"3,514.00","total_whole":"3,514","shares_owned_after":15004.0,"shares_owned_after_display":"15,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"},{"id":3843309,"accession":"0000914475-08-000016","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000914475-08-000016","line_url":"/filing/0000914475-08-000016#line-8","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":2032.0,"total_display":"2,032.00","total_whole":"2,032","shares_owned_after":12204.0,"shares_owned_after_display":"12,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"},{"id":3843308,"accession":"0000914475-08-000016","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000914475-08-000016","line_url":"/filing/0000914475-08-000016#line-7","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":1996.0,"total_display":"1,996.00","total_whole":"1,996","shares_owned_after":17404.0,"shares_owned_after_display":"17,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"},{"id":3843306,"accession":"0000914475-08-000016","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000914475-08-000016","line_url":"/filing/0000914475-08-000016#line-6","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":4.96,"price_display":"4.96","price_state":"stated","total_value":1984.0,"total_display":"1,984.00","total_whole":"1,984","shares_owned_after":19161.0,"shares_owned_after_display":"19,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"},{"id":3843305,"accession":"0000914475-08-000016","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000914475-08-000016","line_url":"/filing/0000914475-08-000016#line-5","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":357.0,"shares_display":"357","price_per_share":4.97,"price_display":"4.97","price_state":"stated","total_value":1774.29,"total_display":"1,774.29","total_whole":"1,774","shares_owned_after":18804.0,"shares_owned_after_display":"18,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"},{"id":3843301,"accession":"0000914475-08-000016","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-08-000016","line_url":"/filing/0000914475-08-000016#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":1530.0,"total_display":"1,530.00","total_whole":"1,530","shares_owned_after":11904.0,"shares_owned_after_display":"11,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"},{"id":3843299,"accession":"0000914475-08-000016","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000914475-08-000016","line_url":"/filing/0000914475-08-000016#line-3","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001376043","owner_name":"Coughlin Timothy P","owner_display_name":"Coughlin Timothy P","owner_url":"/insider/0001376043","role":"Officer (VP and Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (VP and Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":5.03,"price_display":"5.03","price_state":"stated","total_value":1509.0,"total_display":"1,509.00","total_whole":"1,509","shares_owned_after":14704.0,"shares_owned_after_display":"14,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-12","filed_date":"2008-02-14","scope":"insider"}],"collapsed":true,"next_cursor":"2008-02-12|3843299","ledger_fault":false,"count":{"value":52,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":50,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":52},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001438533","name":"Travere Therapeutics, Inc.","url":"/issuer/0001438533","role":"Director","n_filings":3,"first_seen":"2025-11-04","last_seen":"2026-06-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001339970","name":"aTYR PHARMA INC","url":"/issuer/0001339970","role":"Director","n_filings":1,"first_seen":"2024-06-03","last_seen":"2024-06-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001434316","name":"FATE THERAPEUTICS INC","url":"/issuer/0001434316","role":"Director","n_filings":2,"first_seen":"2016-11-28","last_seen":"2022-06-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000914475","name":"NEUROCRINE BIOSCIENCES INC","url":"/issuer/0000914475","role":"Officer (Chief Financial Officer)","n_filings":30,"first_seen":"2008-02-14","last_seen":"2017-02-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001376043","retrieved_at":"2026-08-27T06:00:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}